Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways.
Adam C, Fusi L, Weiss N, Goller SG, Meder K, Frings VG, Kneitz H, Goebeler M, Houben R, Schrama D, Schmidt M.
Adam C, et al. Among authors: schmidt m.
J Invest Dermatol. 2020 Dec;140(12):2455-2465.e10. doi: 10.1016/j.jid.2020.03.972. Epub 2020 May 4.
J Invest Dermatol. 2020.
PMID: 32376279
Free article.